Sionna Therapeutics, Inc. (SION) Research

Operating as a biopharmaceutical company, Sionna Therapeutics, Inc. is dedicated to transforming the treatment landscape for individuals with cystic fibrosis. This is achieved by developing innovative medicines designed to restore the normal function of the cystic fibrosis transmembrane conductance regulator.

Market snapshot

Symbol
SION
Price
$37.30
Day change
+1.55%
Market cap
$1.7B
P/E ratio
-19.33x
52-week range
13.81-48.445
Sector
Healthcare
Industry
Biotechnology
Next earnings
in 2 months
Analyst price target
$54.00

Peer companies

  • AbCellera Biologics Inc. (ABCL)
  • Ardelyx, Inc. (ARDX)
  • Biohaven Ltd. (BHVN)
  • Celldex Therapeutics, Inc. (CLDX)
  • Immunome, Inc. (IMNM)
  • Janux Therapeutics, Inc. (JANX)
  • Maze Therapeutics, Inc. (MAZE)
  • Vera Therapeutics, Inc. (VERA)

Recent insider activity

  • Stelzer Laurie — A-Award (17340 shares) on 2026-06-17
  • Viney Joanne L. — A-Award (17340 shares) on 2026-06-17
  • Thompson Peter A. — A-Award (17340 shares) on 2026-06-17
  • RA CAPITAL MANAGEMENT, L.P. — A-Award (17340 shares) on 2026-06-17
  • Ruddy Marcella K. — A-Award (17340 shares) on 2026-06-17

Open Sionna Therapeutics, Inc. (SION) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.